The long-term benefits of nucleos(t)ide analogs in compensated HBV cirrhotic patients with no or small esophageal varices: A 12-year prospective cohort study

Journal of Hepatology

Volumn 63, Issue 5, 2015, Pages 1118-1125

  Lampertico, Pietro ^a   Invernizzi, Federica ^a   Viganò, Mauro ^a   Loglio, Alessandro ^a   Mangia, Giampaolo ^a   Facchetti, Floriana ^a   Primignani, Massimo ^a   Jovani, Manol ^a   Iavarone, Massimo ^a   Fraquelli, Mirella ^a   Casazza, Giovanni ^b   De Franchis, Roberto ^b   Colombo, Massimo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Cirrhosis; Esophageal varices; Gastrointestinal bleeding; HBsAg clearance; Hepatitis B virus; Hepatocellular carcinoma; Nucleos(t)ide analogs; Transient elastography

Indexed keywords

ADEFOVIR; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; TENOFOVIR; ADENINE; ANTIVIRUS AGENT; HEPATITIS B(E) ANTIGEN; IMMUNOSUPPRESSIVE AGENT; NUCLEOSIDE; PHOSPHONIC ACID DERIVATIVE; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS DNA;

ADOLESCENT; ADULT; AGED; BODY MASS; CHILD; CHILD PUGH SCORE; COHORT ANALYSIS; COMPENSATED LIVER CIRRHOSIS; DIGESTIVE ENDOSCOPE; DISEASE COURSE; DRUG SUBSTITUTION; DRUG SURVEILLANCE PROGRAM; DRUG WITHDRAWAL; ECHOGRAPHY; ELASTOGRAPHY; ESOPHAGOGASTRODUODENOSCOPY; ESOPHAGUS VARICES; FEMALE; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; HEPATITIS B; HUMAN; INCIDENCE; LIMIT OF QUANTITATION; LIVER HISTOLOGY; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PORTAL HYPERTENSION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; SENSITIVITY AND SPECIFICITY; TRANSIENT ELASTOGRAPHY; VIRAL CLEARANCE; ANALOGS AND DERIVATIVES; COMPLICATION; DIAGNOSTIC IMAGING; DOSE RESPONSE; DRUG EFFECTS; ESOPHAGEAL AND GASTRIC VARICES; FORECASTING; GENETICS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; IMMUNOLOGY; ITALY; LIVER; LIVER CIRRHOSIS; MIDDLE AGED; PATHOLOGY; PROCEDURES; SURVIVAL RATE; TRENDS; VIROLOGY;

ADENINE; ADULT; AGED; ANTIVIRAL AGENTS; DNA, VIRAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELASTICITY IMAGING TECHNIQUES; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; FOLLOW-UP STUDIES; FORECASTING; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ITALY; LAMIVUDINE; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NUCLEOSIDES; ORGANOPHOSPHONATES; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE INHIBITORS; SURVIVAL RATE; TENOFOVIR;

EID: 84945464813     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2015.06.006     Document Type: Article

References (52)

1. G. D'Amico, G. Garcia-Tsao, and L. Pagliaro Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies J Hepatol 44 2006 217 231
2. C. Ripoll, R. Groszmann, G. Garcia-Tsao, and et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis Gastroenterology 133 2007 481 488
3. M. Viganò, and P. Lampertico Antiviral drugs for HBV liver disease Expert Opin Biol Ther 11 2011 285 300
4. S. Pol, and P. Lampertico First-line treatment of chronic hepatitis B with entecavir or tenofovir in 'real-life' settings: from clinical trials to clinical practice J Viral Hepat 19 2012 377 386
5. M. Iavarone, and M. Colombo HBV-related HCC, clinical issues and therapy Dig Liver Dis 43 2011 S32 S39
6. E. Christensen, L. Fauerholdt, P. Schlichting, and et al. Aspects of the natural history of gastrointestinal bleeding in cirrhosis and the effect of prednisone Gastroenterology 81 1981 944 952
7. North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study N Engl J Med 319 1988 983 989
8. M. Zoli, C. Merkel, D. Magalotti, and et al. Natural history of cirrhotic patients with small esophageal varices: a prospective study Am J Gastroenterol 95 2000 503 508
9. M. Merli, G. Nicolini, S. Angeloni, and et al. Incidence and natural history of small esophageal varices in cirrhotic patients J Hepatol 38 2003 266 272
10. C. Merkel, R. Marin, P. Angeli, and et al. A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis Gastroenterology 127 2004 476 484
11. R.J. Groszmann, G. Garcia-Tsao, J. Bosch, and et al. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis N Engl J Med 353 2005 2254 2261
12. N.D. Grace, R.J. Groszmann, G. Garcia-Tsao, and et al. Portal hypertension and variceal bleeding: an AASLD single-topic symposium Hepatology 28 1998 868 880
13. R. de Franchis Developing consensus in portal hypertension J Hepatol 25 1996 390 394
14. R. de Franchis Updating Consensus in Portal Hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension J Hepatol 33 2000 846 852
15. R. de Franchis Baveno V Faculty Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension J Hepatol 53 2010 762 768
16. P. Lampertico, M. Viganò, E. Manenti, and et al. Low resistance to Adefovir combined with Lamivudine: a 3 year study of 145 Lamivudine resistant hepatitis B patients Gastroenterology 133 2007 1445 1451
17. P. Marcellin, E. Gane, M. Buti, and et al. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study Lancet 381 2013 468 475
18. R. Zoutendijk, J.G. Reijnders, F. Zoulim, and et al. Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis Gut 62 2013 760 765
19. Y.F. Liaw, J.J. Sung, W.C. Chow, and et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease N Engl J Med 351 2004 1521 1531
20. T.T. Chang, Y.F. Liaw, S.S. Wu, and et al. Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B Hepatology 52 2010 886 893
21. H. Koga, T. Ide, K. Oho, and et al. Lamivudine treatment-related morphological changes of esophageal varices in patients with liver cirrhosis Hepatol Res 37 2007 503 509
22. S. Manolakopoulos, C. Triantos, J. Theodoropoulos, and et al. Antiviral therapy reduces portal pressure in patients with cirrhosis due to HBeAg-negative chronic hepatitis B and significant portal hypertension J Hepatol 51 2009 468 474
23. P. Lampertico, M. Viganò, E. Manenti, and et al. Five years of sequential LAM to LAM+ADV therapy suppresses HBV replication in most HBeAg negative cirrhotics, preventing decompensation but not hepatocellular carcinoma J Hepatol 44 2006 S38
24. R. de Franchis Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension J Hepatol 43 2005 167 176
25. G. Garcia-Tsao, A.J. Sanyal, N.D. Grace, and W. Carey Practice Guidelines Committee of the American Association for the Study of Liver Diseases; Practice Parameters Committee of the American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis Hepatology 46 2007 922 938
26. L. Stuyver, C. Van Geyt, S. De Gendt, and et al. Line probe assay for monitoring drug resistance in hepatitis B virus-infected patients during antiviral therapy J Clin Microbiol 38 2000 702 707
27. L. Castera, X. Forns, and A. Alberti Non-invasive evaluation of liver fibrosis using transient elastography J Hepatol 48 2008 835 847
28. M. Viganò, S. Paggi, P. Lampertico, and et al. Dual cut-off transient elastography to assess liver fibrosis in chronic hepatitis B: a cohort study with internal validation Aliment Pharmacol Ther 34 2011 353 362
29. R.N. Pugh, I.M. Murray-Lyon, J.L. Dawson, and et al. Transection of the oesophagus for bleeding oesophageal varices Br J Surg 60 1973 646 649
30. C. Child, J.G. Turcotte, and C. Child The liver and portal hypertension 1964 Saunders Philadelphia Surgery and portal hypertension: 1-85
31. M. Colombo, R. de Franchis, E. Del Ninno, and et al. Hepatocellular carcinoma in Italian patients with cirrhosis N Engl J Med 325 1991 675 680
32. M. Borzio, F. Borzio, R. Macchi, and et al. The evaluation of fine-needle procedures for the diagnosis of focal liver lesions in cirrhosis J Hepatol 20 1994 117 121
33. J. Bruix, M. Sherman, J.M. Llovet, and et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver J Hepatol 35 2001 421 430
34. J. Bruix, and M. Sherman Management of hepatocellular carcinoma Hepatology 42 2005 1208 1236
35. B.A. Runyon Care of patients with ascites N Engl J Med 330 1994 337 342
36. European Association for the Study of the Liver EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis J Hepatol 53 2010 397 417
37. P. Lampertico, M. Viganò, E. Manenti, and et al. Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic resistance to lamivudine Hepatology 42 2005 1414 1419
38. A.S. Lok, and B.J. McMahon American Association for the Study of Liver Disease Practice Guidelines. Chronic hepatitis B: update 2009 Hepatology 50 2009 661 662
39. EASL clinical practice guidelines: management of chronic hepatitis B virus infection B J Hepatol 57 2012 167 185
40. J. Bruix, and M. Sherman American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update Hepatology 53 2011 1020 1022
41. European Association for the Study of the Liver European Organisation for Research and Treatment of Cancer EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma J Hepatol 56 2012 908 943
42. J. Vorobioff, R.J. Groszmann, E. Picabea, and et al. Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: a 10-year prospective study Gastroenterology 111 1996 701 709
43. P. Calès, H. Desmorat, J.P. Vinel, and et al. Incidence of large oesophageal varices in patients with cirrhosis: application to prophylaxis of first bleeding Gut 31 1990 1298 1302
44. H.A. Shah, Z. Azam, J. Rauf, and et al. Carvedilol vs. esophageal variceal band ligation in the primary prophylaxis of variceal hemorrhage: a multicentre randomized controlled trial J Hepatol 60 2014 757 764
45. C. Ripoll, R.J. Groszmann, G. Garcia-Tsao, and et al. Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis J Hepatol 50 2009 923 928
46. L. Castera Hepatitis B: are non-invasive markers of liver fibrosis reliable? Liver Int 34 2014 91 96
47. E. Ogawa, N. Furusyo, M. Murata, and et al. Longitudinal assessment of liver stiffness by transient elastography for chronic hepatitis B patients treated with nucleoside analog Hepatol Res 41 2011 1178 1188
48. R. D'Ambrosio, A. Aghemo, M. Fraquelli, and et al. The diagnostic accuracy of Fibroscan for cirrhosis is influenced by liver morphometry in HCV patients with a sustained virological response J Hepatol 59 2013 251 256
49. G. Fattovich, F. Bortolotti, and F. Donato Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors J Hepatol 48 2008 335 352
50. G.V. Papatheodoridis, G.N. Dalekos, C. Yurdaydin, and et al. Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir J Hepatol 62 2015 363 370
51. A. Berzigotti, M. Reig, J.G. Abraldes, and et al. Portal hypertension on the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis Hepatology 61 2015 526 536
52. T. Stroffolini, P.L. Almasio, E. Sagnelli, and et al. Evolving clinical landscape of chronic hepatitis B: a multicenter Italian study J Med Virol 81 2009 1999 2006